+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Female Contraceptive Market by Product Type (Implants, Injectables, Intrauterine Devices), Mechanism (Hormonal, Non-Hormonal), End User Age, Distribution Channel - Global Forecast 2025-2030- Product Image
Female Contraceptive Market by Product Type (Implants, Injectables, Intrauterine Devices), Mechanism (Hormonal, Non-Hormonal), End User Age, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Female Contraceptive Market by Product Type (Implants, Injectables, Intrauterine Devices), Mechanism (Hormonal, Non-Hormonal), End User Age, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904506
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The female contraceptive market is undergoing robust transformation, underpinned by innovation, regulatory evolution, and shifts in healthcare delivery. Decision-makers seeking growth and resilience opportunities benefit from strategic insight into the drivers and disruptors defining this sector.

Market Snapshot: Female Contraceptive Market Growth & Dynamics

The Female Contraceptive Market grew from USD 9.91 billion in 2024 to USD 10.57 billion in 2025. It is expected to continue growing at a CAGR of 6.44%, reaching USD 14.41 billion by 2030. This growth trajectory reflects steady demand for advanced contraceptive solutions, alongside increased policy focus on reproductive health. Sector expansion is supported by long-acting technologies, regulatory reforms, and diversified distribution across multiple geographies.

Scope & Segmentation: Comprehensive Coverage Across the Female Contraceptive Market

  • Product Types: Implants, injectables, intrauterine devices (copper IUDs, hormonal IUDs), combined pills (first, second, third, fourth generation), and progestin-only pills.
  • Mechanism: Hormonal options (combined and progestin-only) and non-hormonal choices tailored for distinct clinical needs.
  • End User Age Groups: Segments spanning 15-24 years, 25-34 years, and 35-49 years reflect varied behavioral patterns and regimen preferences.
  • Distribution Channels: Clinics, hospital pharmacies, online pharmacies, and retail pharmacies deliver products through both traditional and digital paths to reach end-users efficiently.
  • Geographic Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as the United Kingdom, Germany, France, Saudi Arabia, South Africa, Nigeria), and Asia-Pacific (notably China, India, Japan, Australia, Southeast Asia, and others).
  • Technologies: Advancements include digital health integration, adherence monitoring applications, and sustainable device design, which shape new standards for efficacy, user experience, and ecological responsibility.
  • Industry Players: Bayer Aktiengesellschaft, Organon & Co., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson, AbbVie Inc., Viatris Inc., Perrigo Company plc, Gedeon Richter Plc, Novartis AG.

Key Takeaways for Decision-Makers

  • Long-acting reversible contraceptives and non-hormonal alternatives are reshaping product portfolios to address shifting patient and clinical preferences.
  • Regulatory updates across major economies encourage broader access and minimize administrative barriers, streamlining market entry and user reach.
  • Digital health platforms such as telemedicine and mobile adherence tools drive patient engagement and data collection, supporting both clinical outcomes and commercial strategies.
  • Sustainability considerations now influence device development, as manufacturers adopt biodegradable and recyclable materials in response to environmental demands.
  • Strategic collaborations between pharmaceutical leaders, biotech innovators, and technology partners facilitate the co-development of integrated solutions, enhancing competitive positioning.
  • Regional healthcare systems exhibit uneven adoption patterns, requiring tailored engagement strategies to reflect local norms, reimbursement models, and infrastructure maturity.

Tariff Impact: Navigating Regulatory and Supply Chain Disruption in the U.S. Market

The introduction of revised U.S. tariffs in 2025 introduces procurement challenges for manufacturers reliant on international raw materials and active ingredients. To mitigate cost volatility, market leaders are increasing domestic production capacity, diversifying suppliers, and investing in near-shoring solutions. These adaptations support supply chain resilience and offer strategic options to preserve product access and capitalize on evolving market conditions.

Methodology & Data Sources

Insights are based on a robust mixed-method research approach, combining extensive secondary research of regulatory filings, patent data, and literature with primary interviews from sector experts and structured surveys. Results are further strengthened by scenario analysis, cross-verification, and peer review, ensuring reliability and objectivity.

Why This Report Matters

  • Enables leaders to anticipate regulatory changes, product trends, and emerging risks for timely, evidence-based decision making.
  • Supports strategic investment in innovation, supply chain, and market entry by offering granular segmentation and actionable insights across channels, regions, and technologies.
  • Equips stakeholders with a comprehensive view of critical disruptors—such as digital transformation and sustainability imperatives—to shape long-term growth and competitive advantage.

Conclusion

The female contraceptive market is evolving rapidly, requiring senior decision-makers to harness adaptation and innovation across products, partnerships, and policy environments. Strategic foresight will define success for organizations navigating this dynamic and essential healthcare sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing consumer demand for non-hormonal contraceptive devices with digital cycle-tracking integrations
5.2. Surge in telehealth consultations for contraceptive care enhancing accessibility in underserved regions
5.3. Advances in biodegradable and hormone-free implant materials reducing side effects and environmental waste
5.4. Integration of artificial intelligence-powered fertility prediction tools into personalized contraceptive planning
5.5. Expansion of male-focused contraceptive research shifting traditional market dynamics and gender roles
5.6. Regulatory fast-tracking of next-generation vaginal rings and transdermal patches accelerating product approvals
5.7. Collaborations between digital health startups and pharmaceutical firms for adaptive contraception solutions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Female Contraceptive Market, by Product Type
8.1. Introduction
8.2. Implants
8.3. Injectables
8.4. Intrauterine Devices
8.4.1. Copper IUD
8.4.2. Hormonal IUD
8.5. Pills
8.5.1. Combined Pill
8.5.1.1. First Generation
8.5.1.2. Fourth Generation
8.5.1.3. Second Generation
8.5.1.4. Third Generation
8.5.2. Progestin Only Pill
9. Female Contraceptive Market, by Mechanism
9.1. Introduction
9.2. Hormonal
9.2.1. Combined
9.2.2. Progestin Only
9.3. Non-Hormonal
10. Female Contraceptive Market, by End User Age
10.1. Introduction
10.2. 15-24 Years
10.3. 25-34 Years
10.4. 35-49 Years
11. Female Contraceptive Market, by Distribution Channel
11.1. Introduction
11.2. Clinics
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Americas Female Contraceptive Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Female Contraceptive Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Female Contraceptive Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer Aktiengesellschaft
15.3.2. Organon & Co.
15.3.3. Teva Pharmaceutical Industries Ltd.
15.3.4. Pfizer Inc.
15.3.5. Johnson & Johnson
15.3.6. AbbVie Inc.
15.3.7. Viatris Inc.
15.3.8. Perrigo Company plc
15.3.9. Gedeon Richter Plc
15.3.10. Novartis AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FEMALE CONTRACEPTIVE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. FEMALE CONTRACEPTIVE MARKET: RESEARCHAI
FIGURE 24. FEMALE CONTRACEPTIVE MARKET: RESEARCHSTATISTICS
FIGURE 25. FEMALE CONTRACEPTIVE MARKET: RESEARCHCONTACTS
FIGURE 26. FEMALE CONTRACEPTIVE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COPPER IUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COPPER IUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FIRST GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SECOND GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY THIRD GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY PILL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY PILL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 15-24 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 25-34 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 35-49 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 35-49 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 110. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 111. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 112. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 113. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 114. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 115. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 116. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 117. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 118. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 119. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 120. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 121. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 132. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 133. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 214. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 215. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 230. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 231. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 256. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 257. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 258. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 259. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 260. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 261. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 262. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 263. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 264. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 265. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 266. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 267. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 278. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 279. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2024 (USD MILLION)
TABLE 336. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICE

Samples

Loading
LOADING...

Companies Mentioned

  • Bayer Aktiengesellschaft
  • Organon & Co.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Viatris Inc.
  • Perrigo Company plc
  • Gedeon Richter Plc
  • Novartis AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.41 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Contraceptive Market by Type (Emergency Contraceptives, Hormonal, Non-Hormonal), Formulation (Patch, Pill, Ring), Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast 2025-2030 - Product Image

Contraceptive Market by Type (Emergency Contraceptives, Hormonal, Non-Hormonal), Formulation (Patch, Pill, Ring), Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Contraceptive Market Overview, 2025-30 - Product Image

Contraceptive Market Overview, 2025-30

  • Report
  • 118 Pages
  • Global
From
Family Planning Market by Contraceptive Method (Barrier, Hormonal, Intrauterine Device), Distribution Channel (E-Commerce, Hospital Pharmacies, Retail Pharmacies), Sales Type, Age Group - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Family Planning Market by Contraceptive Method (Barrier, Hormonal, Intrauterine Device), Distribution Channel (E-Commerce, Hospital Pharmacies, Retail Pharmacies), Sales Type, Age Group - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global, United States Global, United States
From
Contraceptive Devices Market Report 2025 - Product Image

Contraceptive Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report by Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), and Region with Growth Forecasts, 2025-2030 - Product Image

Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report by Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Female Contraceptive Market

The Female Contraceptive market is an important part of Women's Health, providing women with the ability to control their reproductive health. Contraceptives are used to prevent pregnancy, and can be divided into two main categories: hormonal and non-hormonal. Hormonal contraceptives, such as the pill, patch, and ring, use hormones to prevent ovulation and fertilization. Non-hormonal contraceptives, such as condoms, diaphragms, and spermicides, work by blocking sperm from entering the uterus. In addition to preventing pregnancy, contraceptives can also be used to treat a variety of conditions, such as endometriosis, polycystic ovary syndrome, and acne. Contraceptives can also be used to regulate menstrual cycles and reduce the risk of certain cancers. Some companies in the Female Contraceptive market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.